1. Field of the Invention
The invention relates to catheters used for access to the central venous blood supply of a patient.
2. Description of Related Art
Catheters such as central venous line catheters are typically used in ICU (intensive care unit) patients, particularly in those patients who have suffered a stroke or other brain traumatic event. The central venous line catheters are typically about 8.5-12 French in size and consist of a soft, flexible multi-lumen structure extending 8-12 inches. They are usually introduced through the subclavian or jugular vein, and less preferably in the femoral vein of the patient, serving to provide the caretaker with easy and convenient access to the patient's central blood supply via the central venous system. In this manner general access to the central blood supply is gained, enabling for example delivery of drugs, infusion fluids or nutrition, along with the gathering of patient blood for blood gas analysis and the like.
In many patients, such as ICU patients, fever is a common occurrence. Fever is particularly likely in neuro-ICU patients, and its onset can exacerbate detrimental effects in the brain. Conventional therapies to control fever include treatment with acetaminophen (Tylenol), cooling blankets, ice water bladder lavages, and ice baths. All of these approaches to cooling a patient require excessive time to cool the patient. Moreover, prior methods do not provide for precise control of patient cooling. As recognized herein, to optimize the advantage of cooling a patient, it is important to cool the patient relatively quickly in a controlled fashion.
Recognizing the above-mentioned deleterious effects of fever in ICU patients and the insufficiencies of present temperature control methods and devices, the present assignee has disclosed, in co-pending patent application Ser. Nos. 09/133,813 and 09/063,984, indwelling catheters that can be implanted in the body of a patient to remove heat from the blood supply of the patient. The indwelling catheters of the above-referenced applications are disposed in a heat exchange relationship with the blood supply, and a coolant is circulated through the catheters in a closed loop. These catheters lower the temperature of body tissue and, as mentioned above, can thereby improve the patient's medical outcome.
As understood by the present invention, the advantages of the above-referenced cooling catheters can be implemented into a central venous catheter configuration. As mentioned above, central venous catheters are commonly used in many ICU patients, including neuro-ICU patients, and with these combined recognitions, the present invention understands that it would be advantageous to provide a central venous catheter with the additional capability of cooling a patient. In doing so, the present invention satisfies the goals both of conventional central venous catheters as well as providing a means for effectively and precisely managing patient temperature in a single device.
The present invention overcomes the deficiencies of the prior art by providing a kit of parts comprising a central venous line catheter adapted to actively exchange heat with the body of the patient to thereby raise or lower body temperature as required, along with instructions for proper use of the central venous line catheter. The central venous line catheter is provided with a heat exchange element disposed in heat exchange relationship with the blood of the patient. The heat exchange element houses a circulating fluid therein, with the fluid being automatically cooled or warmed exteriorly of the patient's body in accordance with a patient temperature feedback scheme.
By supplementing the known functions of a central venous line catheter with the function of cooling or warming the patient's blood, the present invention takes advantage of existing access to the venous system and a single incision, reducing the risk of additional complications. The access, typically through the subclavian, jugular or femoral veins, is to the central blood supply, via the central venous system, and is therefore particularly expedient, permitting efficient cooling or warming of patient body temperature. The term central venous system generally relates to the portion of the venous system which returns blood to the right heart, including the inferior and superior vena cava. A particular advantage of the invention is that the cooling function is performed efficiently in tandem with a procedure which is known to be likely attended by fever, thus anticipating such fever and facilitating its control. The heat exchange relationship between the system and the central venous system of the patient can be maintained for a prolonged duration—for example, from about one hour to about twenty-nine days.
The central venous line catheter in accordance with the invention comprises a tubular structure defining a plurality of lumens. At least two of these lumens convey heat exchange fluid to a heat exchange element disposed at a distal, implantable end of the central venous line catheter, while the rest of the lumens serve to provide access to the central blood supply of the patient. The heat exchange element is in fluid communication with a temperature control module via a tubing set which conveys the heat exchange fluid between the components. The temperature control unit, comprising a cooling and/or a heating device, operates in conjunction with a temperature controller to heat or cool the heat exchange fluid depending on a sensed temperature of the patient.
In a less preferred embodiment, the heat exchanger element of the present invention can be made of metal such as steel, and it can assume an appropriate configuration, such as an accordion-like configuration.
The system of the invention operates to maintain patient temperature at a desired level. Any deviation from the desired level automatically triggers corrective action, such as circulating the cooled heat exchange fluid through the central venous line catheter to contend with the onset of fever. Additionally, the system is equipped with indicators which signal to the caretaker of the patient the sensed deviation, by for example sensing the increased workload of the system, in order to warn of adverse physiological changes besetting the patient.
The invention thus provides a system for controlling patient temperature using a central venous line catheter having a heat exchange element. The central venous line catheter is provided with one or more lumens for providing access to the central blood supply of the patient, and with additional lumens for communicating heat exchange fluid to the heat exchange element. Heat exchange fluid temperature is controlled through a feedback loop in which patient temperature is sensed and used to control a temperature control unit comprising a heating device and/or a cooling device in heat exchange relationship with the heat exchange fluid. A tubing set transports the heat exchange fluid between the central venous line and the temperature control unit, with a pump serving to circulate the fluid in a closed fluid circuit in the system.
Many advantages of the present invention will be apparent to those skilled in the art with a reading of this specification in conjunction with the attached drawings, wherein like reference numerals are applied to like elements and wherein:
At its distal, implantable end portion 22, catheter 20 is provided with a heat exchange element such as fluid-carrying inflatable balloon 24 that is radially disposed around the width of the catheter. Balloon 24 is disposed in the vicinity of flexible tip 21 and can be formed from a piece of sheet material 38 or extruded tubing formed into a molded balloon of the desired shape and size and then bound or otherwise fixed to the shaft 25 to form a cavity 36. As illustrated, balloon 24 is shown to have a significantly larger diameter than shaft portion 25 of the catheter. For example, it is contemplated that in some applications the diameter of the inflated balloon will be more than three times that of shaft 25. In one preferred embodiment, the balloon diameter is four millimeters to ten millimeters (4 mm-10 mm). Preferably, the diameter of the balloon is selected to be no more than 40%-60% of the diameter of a typical vena cava. It is to be appreciated that in some cases it may be desirable to maximize the dimension of the shaft 25 in order to facilitate heat exchange fluid flow. This will also minimize the volume of fluid in the balloon 24 and promote a more rapid heat exchange. It will be further appreciated that myriad balloon shapes can be utilized with the invention, including but not limited to spiral or fluted shapes, as disclosed in the aforementioned co-pending patent applications. The particular shape selected would depend on the application and the desired heat exchange and other characteristics. In one preferred embodiment, the balloon 24 is made of urethane, nylon, or PET and is thin-walled, i.e., the balloon 24 has a wall thickness of less than three mils, and more preferably less than one and one-half mils. Also, the balloon 24 preferably is coated with an antimicrobial substance, as well as an anticlot substance, such as heparin.
It is to be understood that the balloon 24 can extend the entire length of the portion of the central venous catheter that is intubated in the patient. Typically, this length is about 15 cm. Under such circumstances, the diameter of the balloon need not be larger than the diameter of a conventional central venous catheter, e.g., the diameter of the balloon can be 12 French, 10 French, or even as small as 7.5 French. More broadly, the balloon diameter, when the balloon extends along the entire length of the intubated portion of the catheter, can be 5-13 French. In an arrangement where multiple balloons are used as detailed below, these balloons can cover the entire length of the intubated portion of the catheter. That is, two balloons of about 7.5 cm each can be used, or three 5 cm balloons, etc.
As can be seen more clearly with reference to
Balloon 24 is in fluid communication with lumens 32 and 34 via a plurality of ports such as inlet port 26 and outlet port 28. Heat exchange fluid circulated in catheter 20 passes from lumen 32 into cavity 36 through inlet port 26, then out of cavity 36 to lumen 34 through outlet port 28. While in the cavity 36, the heat exchange fluid, which is remotely cooled outside the central venous line catheter 20, serves to provide a cold temperature fluid on the inner surface of the sheet material 38 which forms the walls of balloon 24. With a body fluid, such as blood, flowing exteriorly of the balloon 24, heat transfer occurs across the sheet material 38, effectively cooling the body of the patient and countering the effects of a fever. To that end, inlet port 26 is positioned distally of outlet port 28.
Efficient heat transfer is also promoted by specific considerations regarding the cross-sectional shape of the lumens 32 and 34. Specifically, as can be seen from
In order to facilitate fluid flow in and out of cavity 36 of balloon 24, outlet port 28 can be made larger than inlet port 26 to reduce the resistance encountered by the heat exchange fluid as it exits the balloon 24. This relative size difference becomes particularly important when multiple balloons are provided in catheter 20 as is contemplated in accordance with an alternate embodiment of the invention. Specifically, although described in terms of a single balloon 24, it will be appreciated that several such balloons can be provided, disposed axially along the length of shaft 25, as shown in
Catheter 20 is also provided with two or three lumens 42, 44 and 46 in addition to lumens 32 and 34. Lumens 42, 44 and 46 can serve a multiplicity of functions, including infusion of drugs such as chemotherapy, fluids and nutrition, access to syringes for sampling, and accommodation of various sensors, such as thermistors to monitor the patient, thus generally providing access to the central blood supply as dictated by the particular application. Additionally, central lumen 44 may be made of a different diameter than side lumens 42 and 46 in order to better support a guidewire for instance. The lumens extend substantially the full length of catheter 20, from proximal end portion 27 to distal end portion 22. The number of lumens provided can be varied depending on the particular application.
It will also be appreciated that the heat exchange element does not necessarily need to be in the form of a balloon such as balloon 24. Rather, arrangements such as an array of flexible hollow fibers through which the heat exchange fluid is circulated can also be used, thus affording greater surface area for heat exchange interaction. Such an arrangement, along with other heat exchange element arrangements which can be used with the invention, is disclosed in the afore-mentioned co-pending U.S. patent application Ser. No. 09/133,813, herein incorporated by reference in its entirety. A hollow fiber heat exchange element configuration is shown in
With reference again to
Preferably, the target temperature is selected to be normal body temperature, and any deviation from this temperature, for example induced by the onset of fever, is sensed by the probe 54 and automatically corrected by the system of the invention. Temperature correction is effected by for example activating temperature control unit 57 of temperature control module 50. In cooling applications, temperature control unit 57 causes cooling of the circulating fluid and ultimately the cooling of the patient's core body temperature, which is monitored by probe 54. When normal temperature is achieved, the temperature control unit 57 can then be automatically switched off or its cooling effect reduced by the temperature controller 55. Suitable temperature control algorithms taking into account performance parameters of system components and system time constants are implemented by temperature controller 55 to effect accurate temperature control. For more expedient temperature control, module 50 may also be provided with a heating device as part of the temperature control unit 57, which heating device can also be automatically activated, using feedback from probe 54, to for example prevent overshooting the desired target temperature or range, or even to induce hyperthermia in some situations. It will be appreciated that probe 54 can be used to provide temperature feedback from any part of the patient's body, rectally for instance, or it can provide temperature information anywhere in the fluid circuit, which information can then be correlated to the patient's core temperature using known parameters such as heat conductivity of different portions of the system and patient data such as weight, height, age, etc. Additionally, more than one probe can be used to provide combinations of readings from the patient and/or from the system to improve accuracy under some circumstances.
In accordance with the invention, the feedback scheme can be used to maintain desired temperature conditions for a patient. Specifically, the system can be used to control any temperature deviations from an acceptable temperature range, which may be a normothermic range, whereby probe 54 will trigger cooling or heating of the patient's body depending on this sensed deviation from the predetermined range. Moreover, since this deviation is generally indicative of certain physiological activity of which the patient's caretaker should be apprised, the operation of the system can be used as an indication that this physiological activity is taking place. For instance, when the cooling operation of temperature control unit 57 is activated due to a rise in the patient's core body temperature, the system cooling activity, as reflected in the increased workload of the cooling componentry of the system, is then used to indicate to the caretaker, audibly or visibly using an alarm or other status indicator device (not shown) for instance, that the patient's body is attempting to enter a fever state. Appropriate measures can then be taken. Parameters other than workload can be used to provide this indication, such as the slope of the temperature feedback along with the sign of the slope. Alternatively, a direct indication of patient temperature as sensed by the probe 54 can be used. In this manner, use of the system for extended periods of time—for example, from about one hour to about twenty-nine or more days—is facilitated.
In cross-reference to
Additionally, as best seen in
Device Description:
The COOL LINE™ Heat Exchange Catheter is a sterile, single use flexible 8.5 F catheter designed for placement in the central venous circulation from an insertion site in the jugular, subclavian, or femoral veins. The COOL LINE™ catheter is to be connected to an ALSIUS single use disposable COOLGARD™ Tubing Set (supplied separately) and the COOLGARD™ System. A dilator and guidewire are required for the percutaneous insertion of the COOL LINE™ catheter. Two lumens are available for infusion, measuring central venous pressure and sampling. Flow rates: Proximal port (blue) 1400 ml/hr. Distal Guidewire Port (brown) 2200 ml/hr. The COOL LINE™ blood contact surfaces are Duraflo® & treated.
Indications for Use:
The ALSIUS COOL LINE™ Catheter in combination with the COOLGARD™ System is for reducing fever in neurointensive care unite patients.
Safety and Efficacy Consideration:
Product designed for single use only. Do not resterilize or reuse. Do not reinsert, once removed from patient. Do not alter the catheter in any way. Central venous catheterization should only be performed by well-trained personnel well versed in anatomical landmarks and safe technique. Personnel should also have knowledge of potential complications.
Warning: Do not allow catheter to be placed into right atrium or right ventricle. Placement in right atrium or right ventricle can result in severe patient injury or death.
Contraindications:
1. Bleeding diathesis.
2. Active sepsis.
3. Infection or active bleeding at the site of catheter insertion.
4. Patients with no vascular access.
Warnings and Precautions:
1. Catheter should be placed via a jugular, subclavian, or femoral vein approach only.
2. Do not allow catheter to be placed into right atrium or right ventricle. If placed via the jugular or subclavian veins, catheter should be positioned so that the distal tip of catheter is in the superior vena cava above its junction with the right atrium and parallel to the vessel wall. X-ray examination should be used to ensure that the catheter is not in the right atrium or ventricle. The distal tip of the catheter should be positioned at a level above either the azygos vein or the carina of the trachea, whichever is better visualized.
3. If placed via the femoral vein, the catheter should be positioned so that the distal tip of catheter is in the inferior vena cava below its junction with the right atrium and parallel to the vessel wall.
4. Possible complications with central venous catheters include: atrial or ventricular perforation, cardiac tamponade, air embolism, catheter embolism, thoracic duct laceration, bacteremia, septicemia, thrombosis, inadvertent arterial puncture, hematoma formation, hemorrhage, nerve damage and dysrhythmias.
5. All Luer-Lock connections and covers must be securely tightened to prevent air embolism or fluid or blood loss.
6. Never use excessive force in moving the catheter or guidewire. If resistance is encountered, an x-ray should be performed to identify the reason for the resistance.
7. Passage of the guidewire into the right heart can cause dysrhythmias, right bundle branch block, vessel wall, atrial or ventricular perforation.
8. Use only sterile normal saline for catheter priming and as the circulating fluid in the catheter.
9. Catheter should be routinely inspected for flow rate, security of dressing, correct catheter position and for secure Luer-Lock connection. Use centimeter markings to identify if the catheter position has changed.
10. Only x-ray examination can ensure that the catheter tip has not entered the heart or no longer lies parallel to the vessel wall. If catheter position has changed, perform an x-ray examination to confirm catheter tip position.
11. For blood sampling, temporarily shut off remaining infusion ports through which solutions are being infused.
12. Alcohol and acetone can weaken the structure of the polyurethane material. Care should therefore be taken when infusing drugs containing alcohol or when using alcohol or acetone when performing routine catheter care and maintenance. Alcohol should not be used to doctor the catheter.
13. Use are when infusing drugs that may be affected by cool temperatures (as low as 4° C.).
14. Use of a syringe smaller than 10 ml to irrigate or declot an occluded catheter may cause intraluminal leakage or catheter rupture.
15. Do not infuse into the teal-green Luer-Lock connections.
16. Fever may have infectious and/or non-infectious causes in patients. Mitigation of fever as a sign of possible infection necessitates daily, meticulous assessment for other signs of infection.
More warnings and precautions are located in following instructions.
Catheter Preparation and Insertion:
Use sterile technique.
1. Caution: Use jugular, subclavian, or femoral vein approach only.
2. Place patient in a slight Trendelenburg position as tolerated to reduce the risk of air embolism. If femoral approach is used, place patient in supine position.
3. Prep and drape puncture site as required.
4. Caution: Always prime catheter before it is inserted into patient.
5. Carefully remove catheter from package leaving on catheter membrane cover.
Catheter Preparation Procedure:
1. Remove caps from the inflow and outflow luer hubs. With the catheter cover in place, fill syringe (5 cc or larger) with sterile saline and attach syringe to female inflow luer hub.
2. Warning; Never inject positive pressure into the inflow hub with the outflow luer cap in place.
3. Gently inject saline through catheter until it begins to exit from outflow luer.
4. Using 5 cc or larger syringe, flush the distal and proximal infusion lumens with sterile saline. Clamp or attach injection caps to the proximal infusion lumen. Leave the distal luer uncapped for guidewire passage.
5. Remove catheter membrane cover. Inspect catheter to assure that air has been purged from the heat exchange membrane. Inspect the catheter for leaks.
6. Warning: Do not cut the catheter to alter length.
Catheter Insertion:
1. Obtain jugular, subclavian, or femoral venous access using standard percutaneous techniques. Access should be maintained with a 0.032″ guidewire.
2. Caution: Do not use guidewire larger than 0.032″ with the COOL LINE™ catheter.
3. Holding spring guidewire in place, remove introducer catheter. Precaution: Maintain a firm grip on the guidewire at all times.
4. Enlarge the cutaneous puncture site with cutting edge of scalpel positioned away from the guidewire. Warning: Do not cut guidewire. Use vessel dilator to enlarge site as required. Do not leave vessel dilator in place as an indwelling catheter to minimize risk of possible vessel wall perforation.
5. Thread tip of COOL LINE™ over guidewire. Maintain a sufficiently firm grip on the guidewire during catheter insertion. Grasping near skin, advance catheter into vein with a slight twisting motion.
6. Using centimeter marks on the catheter as positioning reference points, advance catheter to final indwelling position.
7. Hold catheter at desired depth and remove guidewire. If resistance is encountered when attempting to remove the guidewire after catheter placement, the guidewire may be kinked about the tip of the catheter. If resistance is encountered, withdraw the catheter relative to the guidewire about 2-3 cm and attempt to remove the guidewire. If resistance is again encountered remove the guidewire and catheter simultaneously.
8. Caution: Do not apply undue force to the guidewire.
9. Verify that the guidewire in intact upon removal.
10. Check lumen placement by attaching a syringe to the distal and proximal infusion luer hubs and aspirate until a free flow of venous blood is observed. Connect infusion luers to appropriate Luer-Lock line(s) as required. Unused infusion port(s) may be “locked” through the injection cap(s) using standard hospital protocol. Slide clamps are provided on the tubing to occlude flow through the infusion lumens during line and injection cap changes. Precaution: To minimize risk of damage to the tubing from excessive pressure, each clamp must be opened prior to infusing through that lumen.
11. Caution: Do not clamp or occlude inflow or outflow lines. This can cause line blockage and possible failure.
12. Secure and dress catheter temporarily.
13. If subclavian or jugular access is used, verify catheter tip position by chest x-ray immediately after placement. X-ray exam must show the catheter located in the right side of the mediastinum in the SVC with the distal end of the catheter parallel to the vena cava wall. The catheter distal tip must be positioned at a level above either the azygos vein or the carina of the trachea, whichever is better visualized. If the catheter tip of malpositioned, reposition and reverify.
14. If femoral access is used, X-ray examination must show the catheter located in the IVC with the distal end of the catheter parallel to the vena cava wall. If the catheter tip is malpositioned, reposition and reverify.
15. Proximal radiopaque marker indicates proximal end of balloons to ensure that balloons reside completely in vessel. If catheter is malpositioned, reposition and reverify.
16. Secure catheter to patient. Use juncture hub side wings as primary suture site.
17. The Alsius suture tab and clip can also be used as an additional attachment point. Assure that catheter body is secure and does not slide.
18. Caution: Do not suture directly to the outside diameter of the catheter to minimize the risk of cutting or damaging the catheter or impeding catheter flow.
19. Maintain the insertion site with regular meticulous redressing, using aseptic technique.
20. Record on the patient's chart the indwelling catheter length using the centimeter marks on the catheter shaft as reference. Frequent visual reassessment should be made to ensure that the catheter has not moved.
21. Attach a primed Tubing Set to COOL LINE™ Heat Exchange Catheter by connecting the male luer of the tubing set to the green female inflow luer of the COOL LINE™ catheter (labeled “inflow”) and the female luer of the tubing set to the green male outflow luer of the COOL LINE™ catheter (labeled “outflow”). Assure that a sufficient amount of sterile saline is present at the ends of the hubs to make an air free connection. Refer to COOLGARD™ manual for details on COOLGARD™ operation.
22. Warning: Failure to connect the Tubing Set correctly to the catheter could result in catheter failure. Do not attach the Tubing Set to the dark blue or brown luers.
23. Caution: Do not place any stopcocks in line that may be inadvertently shut off. This can cause line blockage and possible failure.
24. Pump saline through tubing set and catheter to assure that all connections are secure and that there is no leaking. Allow any remaining air in system to be purged out.
25. Set COOLGARD™ pump to a setting of 210.
Disconnecting Catheter from COOLGARD™ System:
1. Stop circulation of saline through catheter.
2. Disconnect Tubing Set from catheter.
3. To maintain sterile connections, immediately cap off luer connectors of both catheter and tubing set using sterile luer caps.
Reconnecting Catheter to COOLGARD™ System:
1. Remove luer caps from luer connectors of catheter and tubing set and discard.
2. Attach Tubing Set to COOL LINE™ Heat Exchange Catheter by connecting the male luer of the Tubing Set to the female inflow luer of the COOL LINE™ catheter and the female luer of the Tubing Set to the male outflow luer of the COOL LINE™ catheter. Assure that a sufficient amount of sterile saline is present at the ends of the hubs make an air free connection.
3. Warning: Failure to connect the tubing set correctly to the catheter could result in catheter failure.
4. Caution: Do not place any extra stopcocks in line that may be inadvertently shut off. This can cause line blockage and possible failure.
Catheter Removal:
1. Stop all pumping of saline through the catheter.
2. Disconnect Tubing Set from catheter.
3. Place patient in supine position. Remove dressing. Remove sutures from suture site.
4. Slowly remove catheter from patient. As catheter exits the site apply pressure with a dressing impermeable to air, e.g. vaseline gauze.
5. Warning: Do not move catheter if resistance is felt. If resistance is encountered, an x-ray should be performed to identify the reason for the resistance.
Sterility
Ethylene oxide sterilized. The COOL LINE™ Catheter is supplied sterile for single use only and should not be resterilized. The package should be inspected prior to use to ensure that the sterility barrier has not been compromised.
Storage
Store at room temperature, 15-40° C.
The above are exemplary modes of carrying out the invention and are not intended to be limiting. It will be apparent to one of ordinary skill in the art that modifications thereto can be made without inventive departure from the spirit and scope of the invention as set forth in the following claims.
This application is a Continuation of prior U.S. application Ser. No. 09/671,114 entitled Kit of Parts Including a Central Venous Line Catheter Having a Temperature Control System, filed on Sep. 28, 2000 now abandoned, which is a Continuation-in-part of U.S. patent application Ser. No. 09/253,109 entitled Central Venous Line Catheter Having Temperature Control System, filed Feb. 19, 1999 now abandoned, which is a Continuation-in-part of U.S. patent application Ser. No. 09/063,984 entitled Indwelling Heat Exchange Catheter and Method of Using Same, filed Apr. 21, 1998, now issued as U.S. Pat. No. 6,126,684, the disclosures of which are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2058780 | Elliott | Oct 1936 | A |
2077453 | Albright | Apr 1937 | A |
2308484 | Auzin et al. | Jan 1943 | A |
2876769 | Cordova | Mar 1959 | A |
3125096 | Antiles et al. | Mar 1964 | A |
3142158 | Podolsky | Jul 1964 | A |
3238944 | Hirschhorn | Mar 1966 | A |
3282267 | Eidus | Nov 1966 | A |
3327713 | Eidus | Jun 1967 | A |
3425419 | Dato | Feb 1969 | A |
3504674 | Swenson et al. | Apr 1970 | A |
3738372 | Shioshvili | Jun 1973 | A |
3776241 | Magilton | Dec 1973 | A |
3897790 | Magilton et al. | Aug 1975 | A |
3913581 | Ritson et al. | Oct 1975 | A |
4010795 | Stenberg | Mar 1977 | A |
4111209 | Wolvek et al. | Sep 1978 | A |
4154245 | Daily | May 1979 | A |
4249923 | Walda | Feb 1981 | A |
4298006 | Parks | Nov 1981 | A |
4416280 | Carpenter et al. | Nov 1983 | A |
4416281 | Cooper et al. | Nov 1983 | A |
4546759 | Solar | Oct 1985 | A |
4583969 | Mortensen | Apr 1986 | A |
4639353 | Takemura et al. | Jan 1987 | A |
4672962 | Hershenson | Jun 1987 | A |
4736748 | Nakamura et al. | Apr 1988 | A |
4745922 | Taylor | May 1988 | A |
4748979 | Hershenson | Jun 1988 | A |
4750493 | Brader | Jun 1988 | A |
4754752 | Ginsburg et al. | Jul 1988 | A |
4759349 | Betz et al. | Jul 1988 | A |
4791930 | Suzuki et al. | Dec 1988 | A |
4813210 | Masuda et al. | Mar 1989 | A |
4823076 | Haines et al. | Apr 1989 | A |
RE32983 | Levy | Jul 1989 | E |
4844074 | Kurucz | Jul 1989 | A |
4850958 | Berry et al. | Jul 1989 | A |
4860744 | Johnson et al. | Aug 1989 | A |
4883455 | Leonard | Nov 1989 | A |
4897082 | Erskine | Jan 1990 | A |
4899741 | Bentley et al. | Feb 1990 | A |
4907589 | Cosman | Mar 1990 | A |
4911689 | Hattler | Mar 1990 | A |
4920963 | Brader | May 1990 | A |
4941475 | Williams et al. | Jul 1990 | A |
4975247 | Badolato et al. | Dec 1990 | A |
4986809 | Hattler | Jan 1991 | A |
4987896 | Nakamatsu | Jan 1991 | A |
RE33561 | Levy | Mar 1991 | E |
5004461 | Wilson | Apr 1991 | A |
5019075 | Spears et al. | May 1991 | A |
5021045 | Buckberg et al. | Jun 1991 | A |
5037383 | Vaslef et al. | Aug 1991 | A |
5041089 | Mueller et al. | Aug 1991 | A |
5059167 | Lundquist et al. | Oct 1991 | A |
5066578 | Wikman-Coffelt | Nov 1991 | A |
5078713 | Varney | Jan 1992 | A |
5092841 | Spears | Mar 1992 | A |
5098376 | Berry et al. | Mar 1992 | A |
5106360 | Ishiwara et al. | Apr 1992 | A |
5122113 | Hattler | Jun 1992 | A |
5135474 | Swan et al. | Aug 1992 | A |
5139496 | Hed | Aug 1992 | A |
5147355 | Friedman et al. | Sep 1992 | A |
5147385 | Beck et al. | Sep 1992 | A |
5151100 | Abele et al. | Sep 1992 | A |
5158534 | Berry et al. | Oct 1992 | A |
5167960 | Ito et al. | Dec 1992 | A |
5174285 | Fontenot | Dec 1992 | A |
5182317 | Winters et al. | Jan 1993 | A |
5191883 | Lennox et al. | Mar 1993 | A |
5196024 | Barath | Mar 1993 | A |
5207640 | Hattler | May 1993 | A |
5211631 | Sheaff | May 1993 | A |
5230862 | Berry et al. | Jul 1993 | A |
5248312 | Langberg | Sep 1993 | A |
5250070 | Parodi | Oct 1993 | A |
5257977 | Eshel | Nov 1993 | A |
5259839 | Burns | Nov 1993 | A |
5261399 | Klatz et al. | Nov 1993 | A |
5262451 | Winters et al. | Nov 1993 | A |
5269758 | Taheri | Dec 1993 | A |
5271743 | Hattler et al. | Dec 1993 | A |
5275595 | Dobak, III | Jan 1994 | A |
5279598 | Sheaff | Jan 1994 | A |
5281213 | Milder et al. | Jan 1994 | A |
5281215 | Milder | Jan 1994 | A |
5304214 | DeFord et al. | Apr 1994 | A |
5324260 | O'Neill et al. | Jun 1994 | A |
5324286 | Fowle | Jun 1994 | A |
5338770 | Winters et al. | Aug 1994 | A |
5342301 | Saab | Aug 1994 | A |
5342693 | Winters et al. | Aug 1994 | A |
5346508 | Hastings | Sep 1994 | A |
5354277 | Guzman et al. | Oct 1994 | A |
5370616 | Keith et al. | Dec 1994 | A |
5382234 | Cornelius et al. | Jan 1995 | A |
5411477 | Saab | May 1995 | A |
5423807 | Milder | Jun 1995 | A |
5433740 | Yamaguchi | Jul 1995 | A |
5437673 | Baust et al. | Aug 1995 | A |
5452582 | Longsworth | Sep 1995 | A |
5474533 | Ward et al. | Dec 1995 | A |
5478309 | Sweezer et al. | Dec 1995 | A |
5486204 | Clifton | Jan 1996 | A |
5486208 | Ginsburg | Jan 1996 | A |
5498261 | Strul | Mar 1996 | A |
5501663 | Hattler et al. | Mar 1996 | A |
5531776 | Ward et al. | Jul 1996 | A |
5545134 | Hilaire et al. | Aug 1996 | A |
5545137 | Rudie et al. | Aug 1996 | A |
5545161 | Imran | Aug 1996 | A |
5549552 | Peters et al. | Aug 1996 | A |
5549559 | Eshel | Aug 1996 | A |
RE35352 | Peters | Oct 1996 | E |
5562606 | Huybregts | Oct 1996 | A |
5607463 | Schwartz et al. | Mar 1997 | A |
5609591 | Daikuzono | Mar 1997 | A |
5609620 | Daily | Mar 1997 | A |
5624392 | Saab | Apr 1997 | A |
5628771 | Mizukawa et al. | May 1997 | A |
5655548 | Nelson et al. | Aug 1997 | A |
5656420 | Chien | Aug 1997 | A |
5693080 | Wallsten et al. | Dec 1997 | A |
5702358 | Witherspoon et al. | Dec 1997 | A |
5702435 | Maytal | Dec 1997 | A |
5716386 | Ward et al. | Feb 1998 | A |
5733319 | Neilson et al. | Mar 1998 | A |
5735809 | Gorsuch | Apr 1998 | A |
5755690 | Saab | May 1998 | A |
5755756 | Freedman, Jr. et al. | May 1998 | A |
5758505 | Dobak, III et al. | Jun 1998 | A |
5759182 | Varney et al. | Jun 1998 | A |
5776176 | Rudie | Jul 1998 | A |
5787715 | Dobak, III et al. | Aug 1998 | A |
5800375 | Sweezer et al. | Sep 1998 | A |
5800486 | Thome et al. | Sep 1998 | A |
5800493 | Stevens et al. | Sep 1998 | A |
5807342 | Musgrave et al. | Sep 1998 | A |
5807395 | Mulier et al. | Sep 1998 | A |
5833624 | Rom et al. | Nov 1998 | A |
5837003 | Ginsburg | Nov 1998 | A |
5861021 | Thome et al. | Jan 1999 | A |
5863654 | Frey et al. | Jan 1999 | A |
5871526 | Gibbs et al. | Feb 1999 | A |
5879316 | Safar et al. | Mar 1999 | A |
5879329 | Ginsburg | Mar 1999 | A |
5902268 | Saab | May 1999 | A |
5902274 | Yamamoto et al. | May 1999 | A |
5902299 | Jayaraman | May 1999 | A |
5906588 | Safar et al. | May 1999 | A |
5957917 | Doiron et al. | Sep 1999 | A |
5957963 | Dobak, III | Sep 1999 | A |
5975081 | Hood et al. | Nov 1999 | A |
5989238 | Ginsburg | Nov 1999 | A |
6004289 | Saab | Dec 1999 | A |
6019783 | Philips | Feb 2000 | A |
6042559 | Dobak | Mar 2000 | A |
6093199 | Brown et al. | Jul 2000 | A |
6096068 | Dobak | Aug 2000 | A |
6110139 | Loubser | Aug 2000 | A |
6110168 | Ginsburg | Aug 2000 | A |
6117105 | Bresnaham et al. | Sep 2000 | A |
6126684 | Gobin | Oct 2000 | A |
6146411 | Noda | Nov 2000 | A |
6149670 | Worthen | Nov 2000 | A |
6149673 | Ginsburg | Nov 2000 | A |
6149676 | Ginsburg | Nov 2000 | A |
6149677 | Dobak | Nov 2000 | A |
6165207 | Balding | Dec 2000 | A |
6224624 | Lasheras | May 2001 | B1 |
6231594 | Dae | May 2001 | B1 |
6231595 | Dobak | May 2001 | B1 |
6235048 | Dobak | May 2001 | B1 |
6238428 | Werneth | May 2001 | B1 |
6245095 | Dobak | Jun 2001 | B1 |
6251129 | Dobak | Jun 2001 | B1 |
6251130 | Dobak | Jun 2001 | B1 |
6254626 | Dobak | Jul 2001 | B1 |
6264679 | Keller | Jul 2001 | B1 |
6287326 | Pecor | Sep 2001 | B1 |
6290717 | Philips | Sep 2001 | B1 |
6299599 | Pham | Oct 2001 | B1 |
6306161 | Ginsburg | Oct 2001 | B1 |
6312452 | Dobak | Nov 2001 | B1 |
6325818 | Werneth | Dec 2001 | B1 |
6338727 | Noda | Jan 2002 | B1 |
6364899 | Dobak | Apr 2002 | B1 |
6368304 | Aliberto | Apr 2002 | B1 |
6379378 | Werneth | Apr 2002 | B1 |
6383210 | Magers | May 2002 | B1 |
6393320 | Lasersohn | May 2002 | B2 |
6405080 | Lasersohn | Jun 2002 | B1 |
6409747 | Gobin | Jun 2002 | B1 |
6416533 | Gobin | Jul 2002 | B1 |
6419643 | Shimada | Jul 2002 | B1 |
6428563 | Keller | Aug 2002 | B1 |
6432124 | Worthen | Aug 2002 | B1 |
6436130 | Philips | Aug 2002 | B1 |
6436131 | Ginsburg | Aug 2002 | B1 |
6440158 | Saab | Aug 2002 | B1 |
6447474 | Balding | Sep 2002 | B1 |
6450987 | Kramer | Sep 2002 | B1 |
6450990 | Walker | Sep 2002 | B1 |
6451045 | Walker | Sep 2002 | B1 |
6454792 | Noda | Sep 2002 | B1 |
6454793 | Evans | Sep 2002 | B1 |
6458150 | Evans | Oct 2002 | B1 |
6460544 | Worthen | Oct 2002 | B1 |
6464716 | Dobak | Oct 2002 | B1 |
6468296 | Dobak | Oct 2002 | B1 |
6471717 | Dobak | Oct 2002 | B1 |
6475231 | Dobak | Nov 2002 | B2 |
6478811 | Dobak | Nov 2002 | B1 |
6478812 | Dobak | Nov 2002 | B2 |
6482226 | Dobak | Nov 2002 | B1 |
6491039 | Dobak | Dec 2002 | B1 |
6491716 | Dobak | Dec 2002 | B2 |
6494903 | Pecor | Dec 2002 | B2 |
6497721 | Ginsburg | Dec 2002 | B2 |
6516224 | Laserenhn | Feb 2003 | B2 |
6520933 | Evans | Feb 2003 | B1 |
6527798 | Ginsburg | Mar 2003 | B2 |
6529775 | Whitebook | Mar 2003 | B2 |
6530946 | Noda | Mar 2003 | B1 |
6533804 | Dobak | Mar 2003 | B2 |
6540771 | Dobak | Apr 2003 | B2 |
6544281 | Dae | Apr 2003 | B2 |
6551349 | Lasheras | Apr 2003 | B2 |
6554797 | Worthen | Apr 2003 | B1 |
6558412 | Dobak | May 2003 | B2 |
6572538 | Takase | Jun 2003 | B2 |
6572640 | Balding | Jun 2003 | B1 |
6576001 | Werneth | Jun 2003 | B2 |
6576002 | Dobak | Jun 2003 | B2 |
6581403 | Whitebook | Jun 2003 | B2 |
6582398 | Worthen | Jun 2003 | B1 |
6582455 | Dobak | Jun 2003 | B1 |
6582457 | Dae | Jun 2003 | B2 |
6585692 | Worthen | Jul 2003 | B1 |
6585752 | Dobak | Jul 2003 | B2 |
6589271 | Tzeng | Jul 2003 | B1 |
6595967 | Kramer | Jul 2003 | B2 |
6599312 | Dobak | Jul 2003 | B2 |
6602243 | Noda | Aug 2003 | B2 |
6602276 | Dobak | Aug 2003 | B2 |
6607517 | Dae | Aug 2003 | B1 |
6610083 | Keller | Aug 2003 | B2 |
6620130 | Ginsburg | Sep 2003 | B1 |
6620131 | Pham | Sep 2003 | B2 |
6620188 | Ginsburg | Sep 2003 | B1 |
6620189 | MacHold | Sep 2003 | B1 |
6623516 | Saab | Sep 2003 | B2 |
6635076 | Ginsburg | Oct 2003 | B1 |
6641602 | Balding | Nov 2003 | B2 |
6641603 | Walker | Nov 2003 | B2 |
6645234 | Evans | Nov 2003 | B2 |
6648906 | Lasheras | Nov 2003 | B2 |
6648908 | Dobak | Nov 2003 | B2 |
6652565 | Shimada | Nov 2003 | B1 |
6656209 | Ginsburg | Dec 2003 | B1 |
6660028 | Magers | Dec 2003 | B2 |
6673098 | MacHold | Jan 2004 | B1 |
6676688 | Dobak | Jan 2004 | B2 |
6676689 | Dobak | Jan 2004 | B2 |
6676690 | Werneth | Jan 2004 | B2 |
6679906 | Hammack | Jan 2004 | B2 |
6679907 | Dobak | Jan 2004 | B2 |
6682551 | Worthen | Jan 2004 | B1 |
6685732 | Kramer | Feb 2004 | B2 |
6685733 | Dae | Feb 2004 | B1 |
6692488 | Dobak | Feb 2004 | B2 |
6692519 | Hayes | Feb 2004 | B1 |
6695873 | Dobak | Feb 2004 | B2 |
6695874 | MacHold | Feb 2004 | B2 |
6699268 | Kordis | Mar 2004 | B2 |
6702783 | Dae | Mar 2004 | B1 |
6702839 | Dae | Mar 2004 | B1 |
6702840 | Keller | Mar 2004 | B2 |
6702841 | Nest | Mar 2004 | B2 |
6702842 | Dobak | Mar 2004 | B2 |
6706060 | Tzeng | Mar 2004 | B2 |
6709448 | Walker | Mar 2004 | B2 |
6716188 | Noda | Apr 2004 | B2 |
6716236 | Tzeng | Apr 2004 | B1 |
6719723 | Werneth | Apr 2004 | B2 |
6719724 | Walker | Apr 2004 | B1 |
6719779 | Daoud | Apr 2004 | B2 |
6726653 | Noda | Apr 2004 | B2 |
6726708 | Lasheras | Apr 2004 | B2 |
6726710 | Worthen | Apr 2004 | B2 |
6733517 | Collins | May 2004 | B1 |
6740109 | Dobak | May 2004 | B2 |
6749585 | Aliberto | Jun 2004 | B2 |
6749625 | Pompa | Jun 2004 | B2 |
6752786 | Callister | Jun 2004 | B2 |
6755850 | Dobak | Jun 2004 | B2 |
6755851 | Noda | Jun 2004 | B2 |
20010007951 | Dobak | Jul 2001 | A1 |
20010041923 | Dobak | Nov 2001 | A1 |
20020007203 | Gilmartin | Jan 2002 | A1 |
20020016621 | Werneth | Feb 2002 | A1 |
20020068964 | Dobak | Jun 2002 | A1 |
20020077680 | Noda | Jun 2002 | A1 |
20020091429 | Dobak | Jul 2002 | A1 |
20020111616 | Dea | Aug 2002 | A1 |
20020177804 | Saab | Nov 2002 | A1 |
20020183692 | Callister | Dec 2002 | A1 |
20020193738 | Adrich | Dec 2002 | A1 |
20020193853 | Worthen | Dec 2002 | A1 |
20020193854 | Dobak | Dec 2002 | A1 |
20030078641 | Dobak | Apr 2003 | A1 |
20030114835 | Noda | Jun 2003 | A1 |
20030144714 | Dobak | Jul 2003 | A1 |
20030187489 | Dobak | Oct 2003 | A1 |
20030195465 | Worthen | Oct 2003 | A1 |
20030195466 | Pham | Oct 2003 | A1 |
20030195597 | Keller | Oct 2003 | A1 |
20030216799 | Worthen | Nov 2003 | A1 |
20030225336 | Callister | Dec 2003 | A1 |
20040034399 | Ginsburg | Feb 2004 | A1 |
20040039431 | Machold | Feb 2004 | A1 |
20040044388 | Pham | Mar 2004 | A1 |
20040050154 | Machold | Mar 2004 | A1 |
20040054325 | Ginsburg | Mar 2004 | A1 |
20040073280 | Dae | Apr 2004 | A1 |
20040087934 | Dobak | May 2004 | A1 |
20040102825 | Daoud | May 2004 | A1 |
20040102826 | Lasheras | May 2004 | A1 |
20040102827 | Werneth | May 2004 | A1 |
20040106969 | Dobak | Jun 2004 | A1 |
20040111138 | Bleam | Jun 2004 | A1 |
20040116987 | Magers | Jun 2004 | A1 |
20040116988 | Hammack | Jun 2004 | A1 |
20040127851 | Noda | Jul 2004 | A1 |
Number | Date | Country |
---|---|---|
0352 955 | Jan 1990 | EP |
0 524 662 | Jan 1993 | EP |
0 853 951 | Jul 1998 | EP |
848031 | Oct 1979 | SU |
WO 8402839 | Aug 1984 | WO |
WO 9105528 | May 1991 | WO |
WO 9831312 | Apr 1998 | WO |
WO 9826831 | Jun 1998 | WO |
Number | Date | Country | |
---|---|---|---|
20020111584 A1 | Aug 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09671114 | Sep 2000 | US |
Child | 09939239 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09253109 | Feb 1999 | US |
Child | 09671114 | US | |
Parent | 09063984 | Apr 1998 | US |
Child | 09253109 | US |